Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial

American Heart Journal

Volumn 172, Issue , 2016, Pages 88-95

  Liu, Yong ^a,g   Chen, Ji Yan ^a,g   Huo, Yong ^b,g   Ge, Jun Bo ^c,g   Xian, Ying ^d,g   Duan, Chong Yang ^e,g   Chen, Shi Qun ^a,e,f,g   Jiang, Wei ^d,g   Chen, Ping Yan ^e,g   Tan, Ning ^a,g  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

^f Guangdong Society of Interventional Cardiology   (China)

^g

^h China

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CONTRAST MEDIUM; CREATININE; CYSTATIN C; ELECTROLYTE; FUROSEMIDE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SODIUM CHLORIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHINA; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYDRATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; CHEMICALLY INDUCED; CLINICAL TRIAL; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; FLUID THERAPY; INCIDENCE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; PROCEDURES; PROSPECTIVE STUDY; RADIOGRAPHY; RISK FACTOR; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; CHINA; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FLUID THERAPY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME;

EID: 84959309333     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.10.007     Document Type: Article

References (40)

1. H.M. Sadeghi, G.W. Stone, C.L. Grines, and et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction Circulation 108 2003 2769 2775
2. A. Narula, R. Mehran, G. Weisz, and et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy Eur Heart J 35 2014 1533 1540
3. G. Marenzi, G. Lauri, E. Assanelli, and et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction J Am Coll Cardiol 44 2004 1780 1785
4. S.A. Pyxaras, G. Sinagra, F. Mangiacapra, and et al. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment Am J Cardiol 111 2013 684 688
5. K. Kume, Y. Yasuoka, H. Adachi, and et al. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Cardiovasc Revasc Med 14 2013 253 257
6. American College of Emergency Physicians., Society for Cardiovascular Angiography and Interventions, P.T. O'Gara, and et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 e78 e140
7. M. Maioli, A. Toso, M. Leoncini, and et al. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial Circ Cardiovasc Interv 4 2011 456 462
8. G. Marenzi, C. Ferrari, I. Marana, and et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial JACC Cardiovasc Interv 5 2012 90 97
9. S.S. Brar, V. Aharonian, P. Mansukhani, and et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial Lancet 383 2014 1814 1823
10. S. Windecker, P. Kolh, F. Alfonso, and et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 35 2014 2541 2619
11. H. Trivedi, and W.D. Foley Contrast-induced nephropathy after a second contrast exposure Ren Fail 32 2010 796 801
12. C. Briguori, G. Visconti, N.V. Rivera, and et al. Cystatin C and contrast-induced acute kidney injury Circulation 121 2010 2117 2122
13. M. Maioli, A. Toso, M. Leoncini, and et al. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis Circulation 125 2012 3099 3107
14. N. Tan, Y. Liu, J.Y. Chen, and et al. Use of the contrast volume or grams of iodine-to-creatinine clearance ratio to predict mortality after percutaneous coronary intervention Am Heart J 165 2013 600 608
15. R.G. Newcombe Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998;17:873-90. Erratum in Stat Med 18 8 1999 1293
16. R. Mehran, E.D. Aymong, E. Nikolsky, and et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 2004 1393 1399
17. S. Zoungas, T. Ninomiya, R. Huxley, and et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy Ann Intern Med 151 2009 631 638
18. A. Jurado-Román, F. Hernández-Hernández, J. García-Tejada, and et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention Am J Cardiol 115 2015 1174 1178
19. F.A. Sgura, L. Bertelli, D. Monopoli, and et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction Circ Cardiovasc Interv 3 2010 491 498
20. V. Oduncu, A. Erkol, C.Y. Karabay, and et al. Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention Int J Cardiol 168 2013 3480 3485
21. G. Marenzi, E. Assanelli, I. Marana, and et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 2006 2773 2782
22. M. Masuda, T. Yamada, T. Mine, and et al. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure Am J Cardiol 100 2007 781 786
23. H. Thiele, L. Hildebrand, C. Schirdewahn, and et al. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) trial J Am Coll Cardiol 55 2010 2201 2209
24. E. Aslanger, B. Uslu, C. Akdeniz, and et al. Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty Coron Artery Dis 23 2012 265 270
25. M. Droppa, S. Desch, P. Blase, and et al. Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty Clin Res Cardiol 100 2011 1037 1043
26. P. Thayssen, J.F. Lassen, S.E. Jensen, and et al. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial Circ Cardiovasc Interv 7 2014 216 224
27. K. Torigoe, A. Tamura, T. Watanabe, and et al. 20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C Int J Cardiol 167 2013 2200 2203
28. A. Manari, P. Magnavacchi, E. Puggioni, and et al. Acute kidney injury after primary angioplasty: effect of different hydration treatments J Cardiovasc Med 15 2014 60 67
29. A. Bagai, P.W. Armstrong, A. Stebbins, and et al. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study Am Heart J 166 2013 913 919
30. M. Remmelink, K.D. Sjauw, J.P. Henriques, and et al. Acute left ventricular dynamic effects of primary percutaneous coronary intervention from occlusion to reperfusion J Am Coll Cardiol 53 2009 1498 1502
31. O. Satiroglu, Y. Ciçek, M. Bostan, and et al. Acute change in left ventricle end-diastolic pressure after primary percutaneous coronary intervention in patients with ST segment elevation myocardial infarction Am Heart Hosp J 8 2010 E86 E90
32. G.S. Kim, Y.G. Ko, D.H. Shin, and et al. Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy J Vasc Surg 61 2015 1223 1230
33. A. Wacker-Gußmann, K. Bühren, C. Schultheiss, and et al. Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients AJR Am J Roentgenol 202 2014 452 458
34. F. Ribichini, G. Gambaro, M.S. Graziani, and et al. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions Clin Chem 58 2012 458 464
35. C. Budano, M. Levis, M. D'Amico, and et al. Impact of contrast-induced acute kidney injury definition on clinical outcomes Am Heart J 161 2011 963 971
36. R. Jabara, R.R. Gadesam, L.K. Pendyala, and et al. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention Am J Cardiol 103 2009 1657 1662
37. W. Wróbel, W. Sinkiewicz, M. Gordon, and et al. Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions Kardiol Pol 68 2010 1015 1020
38. S. Hiremath, A. Akbari, W. Shabana, and et al. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence PLoS One 8 3 2013 e60009
39. F. Stacul, A.J. van der Molen, P. Reimer, and et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines Eur Radiol 21 2011 2527 2541
40. F. Stacul, A. Adam, C.R. Becker, and et al. Strategies to reduce the risk of contrast-induced nephropathy Am J Cardiol 98 2006 59K 77K